Anticancer Activities of Citrus Peel Polymethoxyflavones Related to Angiogenesis and Others

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Wang, Liwen ^a   Wang, Jinhan ^a,b   Fang, Lianying ^a   Zheng, Zuliang ^a   Zhi, Dexian ^a   Wang, Suying ^a   Li, Shiming ^c,d   Ho, Chi Tang ^d   Zhao, Hui ^a,e  

^a TIANJIN UNIVERSITY OF COMMERCE   (China)

^b INSTITUTE OF RADIATION MEDICINE   (China)

^c HUANGGANG NORMAL UNIVERSITY   (China)

^d RUTGERS UNIVERSITY   (United States)

^e Department of Hematology and Translation Medicine Centre   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FLAVONE DERIVATIVE; POLYMETHOXYFLAVONE DERIVATIVE; UNCLASSIFIED DRUG; ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; PLANT EXTRACT;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER THERAPY; CARCINOGENESIS; CITRUS; DRUG MECHANISM; HUMAN; METASTASIS INHIBITION; NONHUMAN; REVIEW; CHEMISTRY; COMPLICATION; FRUIT; MALE; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PATHOLOGY; PHYTOTHERAPY; PROCEDURES; TREATMENT OUTCOME;

CITRUS;

ANGIOGENESIS INHIBITORS; ANTINEOPLASTIC AGENTS; CITRUS; FLAVONES; FRUIT; HUMANS; MALE; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PHYTOTHERAPY; PLANT EXTRACTS; TREATMENT OUTCOME;

EID: 84930905377     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/453972     Document Type: Review

References (64)

1. M. Danihelova and E. Sturdik, "Flavonoid natural sources and their importance in the human diet, " Potravinarstvo, vol. 5, no. 4, pp. 12-24, 2011.
2. K. C. Ock, J. C. Sang, andW. O. Song, "Estimateddietaryflavonoid intake and major food sources of U. S. adults, " Journal of Nutrition, vol. 137, no. 5, pp. 1244-1252, 2007.
3. S. Li, H. Wang, L. Guo, H. Zhao, and C.-T. Ho, "Chemistry and bioactivity of nobiletin and its metabolites, " Journal of Functional Foods, vol. 6, pp. 2-10, 2014.
4. J. M. Assini, E. E. Mulvihill, B. G. Sutherland et al., "Naringenin prevents cholesterol-induced systemic inflammation, metabolic dysregulation, and atherosclerosis in Ldlr/mice, " Journal of Lipid Research, vol. 54, no. 3, pp. 711-724, 2013.
5. D. F. Romagnolo and O. I. Selmin, "Flavonoids and cancer prevention: a review of the evidence, " Journal of Nutrition in Gerontology and Geriatrics, vol. 31, no. 3, pp. 206-238, 2012.
6. E. Park and J. M. Pezzuto, "Flavonoids in cancer prevention, " Anti-Cancer Agents in Medicinal Chemistry, vol. 12, no. 8, pp. 836-851, 2012.
7. E. E. Mulvihill and M. W. Huff, "Citrus flavonoids and the prevention of atherosclerosis, " Cardiovascular & Hematological Disorders-Drug Targets, vol. 12, no. 2, pp. 84-91, 2012.
8. E. Meiyanto and A. Hermawan, "Natural products for cancertargeted therapy: citrus flavonoids as potent chemopreventive agents, " Asian Pacific Journal of Cancer Prevention, vol. 13, no. 2, pp. 427-436, 2012.
9. O. I. Aruoma, B. Landes, D. Ramful-Baboolall et al., "Functional benefits of citrus fruits in the management of diabetes, " Preventive Medicine, vol. 54, pp. S12-S16, 2012.
10. S. Hwang, P. Shih, and G. Yen, "Neuroprotective effects of citrus flavonoids, " Journal of Agricultural and FoodChemistry, vol. 60, no. 4, pp. 877-885, 2012.
11. L. Andrews, "Dietary flavonoids for the prevention of colorectal cancer, " Clinical Journal of Oncology Nursing, vol. 17, no. 6, pp. 671-672, 2013.
12. C. La Vecchia, A. Decarli, M. Serafini et al., "Dietary total antioxidant capacity and colorectal cancer: a large case-control study in Italy, " International Journal of Cancer, vol. 133, no. 6, pp. 1447-1451, 2013.
13. X. Gao, A. Cassidy, M. A. Schwarzschild, E. B. Rimm, and A. Ascherio, "Habitual intake of dietary flavonoids and risk of Parkinson disease, " Neurology, vol. 78, no. 15, pp. 1138-1145, 2012.
14. J. K. Song and J. M. Bae, "Citrus fruit intake and breast cancer risk: a quantitative systematic review, " Journal of Breast Cancer, vol. 16, no. 1, pp. 72-76, 2013.
15. A. Cassidy, E. B. Rimm, E. J. OReilly et al., "Dietary flavonoids and risk of stroke in women, " Stroke, vol. 43, no. 4, pp. 946-951, 2012.
16. D. Hanahan andR. A. Weinberg, "Thehallmarks of cancer, " Cell, vol. 100, no. 1, pp. 57-70, 2000.
17. S. Sultana, H. M. Asif, H. M. Nazar, N. Akhtar, J. U. Rehman, and R. U. Rehman, "Medicinal plants combating against cancer-a green anticancer approach, " Asian Pacific Journal of Cancer Prevention, vol. 15, no. 11, pp. 4385-4394, 2014.
18. X. Grana and E. P. Reddy, "Cell cycle control in mammalian cells: Role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs), " Oncogene, vol. 11, no. 2, pp. 211-219, 1995.
19. K. Vermeulen, D. R. van Bockstaele, and Z. N. Berneman, "The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer, " Cell Proliferation, vol. 36, no. 3, pp. 131-149, 2003.
20. K. I. Park, H. S. Park, A. Nagappan et al., "Induction of the cell cycle arrest and apoptosis by flavonoids isolated from Korean Citrus aurantium L. in non-small-cell lung cancer cells, " Food Chemistry, vol. 135, no. 4, pp. 2728-2735, 2012.
21. E. J. Choi, "Hesperetin induced G1-phase cell cycle arrest in human breast cancer MCF-7 cells: involvement of CDK4 and p21, " Nutrition and Cancer, vol. 59, no. 1, pp. 115-119, 2007.
22. A. A. Alshatwi, E. Ramesh, V. S. Periasamy, and P. Subash-Babu, "The apoptotic effect of hesperetin on human cervical cancer cells is mediated through cell cycle arrest, death receptor, and mitochondrial pathways, " Fundamental and Clinical Pharmacology, vol. 27, no. 6, pp. 581-592, 2013.
23. D. Arul and P. Subramanian, "Naringenin (citrus flavonone) induces growth inhibition, cell cycle arrest and apoptosis in human hepatocellular carcinoma cells, " Pathology and Oncology Research, vol. 19, no. 4, pp. 763-770, 2013.
24. K. L. Morley, P. J. Ferguson, and J. Koropatnick, "Tangeretin and nobiletin induce G1 cell cycle arrest but not apoptosis in human breast and colon cancer cells, " Cancer Letters, vol. 251, no. 1, pp. 168-178, 2007.
25. N. Charoensinphon, P. Qiu, P. Dong et al., "5-demethyltangeretin inhibits human nonsmall cell lung cancer cell growth by inducing G2/M cell cycle arrest and apoptosis, " Molecular Nutrition & Food Research, vol. 57, no. 12, pp. 2103-2111, 2013.
26. P. Qiu, H. Guan, P. Dong et al., "The p53-, Bax-and p21-dependent inhibition of colon cancer cell growth by 5-hydroxy polymethoxyflavones, " Molecular Nutrition and Food Research, vol. 55, no. 4, pp. 613-622, 2011.
27. H. Li, B. Yang, J. Huang et al., "Naringin inhibits growth potential of human triple-negative breast cancer cells by targeting β-catenin signaling pathway, " Toxicology Letters, vol. 220, no. 3, pp. 219-228, 2013.
28. M. H. Han, W. S. Lee, J. N. Lu et al., "Citrus aurantium L. exhibits apoptotic effects on U937 human leukemia cells partly through inhibition of Akt, " International Journal of Oncology, vol. 40, no. 6, pp. 2090-2096, 2012.
29. A. Ghorbani, M. Nazari, M. Jeddi-Tehrani, and H. Zand, "The citrus flavonoid hesperidin induces p53 and inhibits NF-κB activation in order to trigger apoptosis in NALM-6 cells: involvement of PPARγ-dependent mechanism, " European Journal of Nutrition, vol. 51, no. 1, pp. 39-46, 2012.
30. O. Wesolowska, J. Wisniewski, K. Sroda-Pomianek et al., "Multidrug resistance reversal and apoptosis induction in human colon cancer cells by some flavonoids present in citrus plants, " Journal of Natural Products, vol. 75, no. 11, pp. 1896-1902, 2012.
31. A. Gosslau, K. Y. Chen, C.-T. Ho, and S. Li, "Anti-inflammatory effects of characterized orange peel extracts enriched with bioactive polymethoxyflavones, " Food Science andHumanWellness, vol. 3, no. 1, pp. 26-35, 2014.
32. I. N. Sergeev, C. T. Ho, S. Li, J. Colby, and S. Dushenkov, "Apoptosis-inducing activity of hydroxylated polymethoxyf lavones and polymethoxyflavones from orange peel in human breast cancer cells, "Molecular Nutrition and Food Research, vol. 51, no. 12, pp. 1478-1484, 2007.
33. C. S. Lai, S. Li, C. B. Liu et al., "Effective suppression of azoxymethane-induced aberrant crypt foci formation in mice with citrus peel flavonoids, " Molecular Nutrition and Food Research, vol. 57, no. 3, pp. 551-555, 2013.
34. S. Li, Y. C. Lin, C. T. Ho et al., "Formulated extract frommultiple citrus peels impairs dendritic cell functions and attenuates allergic contact hypersensitivity, " International Immunopharmacology, vol. 20, no. 1, pp. 12-23, 2014.
35. N. Nalini, S. Aranganathan, and J. Kabalimurthy, "Chemopreventive efficacy of hesperetin (citrus flavonone) against 1, 2-dimethylhydrazine-induced rat colon carcinogenesis, " Toxicology Mechanisms and Methods, vol. 22, no. 5, pp. 397-408, 2012.
36. L. Ye, F. L. Chan, S. Chen, and L. K. Leung, "The citrus flavonone hesperetin inhibits growth of aromatase-expressing MCF-7 tumor in ovariectomized athymic mice, " Journal of Nutritional Biochemistry, vol. 23, no. 10, pp. 1230-1237, 2012.
37. C. Cande, N. Vahsen, C. Garrido, and G. Kroemer, "Apoptosisinducing factor (AIF): caspase-independent after all, " Cell Death and Differentiation, vol. 11, no. 6, pp. 591-595, 2004.
38. C. Lu, F. Zhu, Y. Cho et al., "Cell apoptosis: requirement of H2AX in DNA ladder formation, but not for the activation of caspase-3, " Molecular Cell, vol. 23, no. 1, pp. 121-132, 2006.
39. J. Wang, Y. Duan, D. Zhi et al., "Pro-apoptotic effectsof thenovel tangeretin derivate 5-acetyl-6, 7, 8, 4′-tetramethylnortangeretin onMCF-7 breast cancer cells, " Cell Biochemistry and Biophysics, 2014.
40. C. Fimognari, M. Nusse, M. Lenzi, D. Sciuscio, G. Cantelli-Forti, and P. Hrelia, "Sulforaphane increases the efficacy of doxorubicin in mouse fibroblasts characterized by p53 mutations, " Mutation Research: Fundamental and Molecular Mechanisms of Mutagenesis, vol. 601, no. 1-2, pp. 92-101, 2006.
41. A. Bast, H. Kaiserova, G. J. den Hartog, G. R. Haenen, and W. J. F. van der Vijgh, "Protectors against doxorubicin-induced cardiotoxicity: flavonoids, " Cell Biology and Toxicology, vol. 23, no. 1, pp. 39-47, 2007.
42. A. Hermawan, "Hesperidin increase cytotoxic effect of doxorubicin in MCF-7 cells, " Indonesian Journal of Pharmacy, vol. 21, no. 1, pp. 8-16, 2010.
43. A. Ahmadi, S. J. Hosseinimehr, F. Naghshvar, E. Hajir, and M. Ghahremani, "Chemoprotective effects of hesperidin against genotoxicity induced by cyclophosphamide in mice bone marrow cells, "Archives of Pharmacal Research, vol. 31, no. 6, pp. 794-797, 2008.
44. J. E. Talmadge and I. J. Fidler, "AACR centennial series: the biology of cancer metastasis: historical perspective, " Cancer Research, vol. 70, no. 14, pp. 5649-5669, 2010.
45. E. Lee, D. Kim, W. Kim, and S. Moon, "Naringin inhibitsmatrix metalloproteinase-9 expression and AKT phosphorylation in tumor necrosis factor-α-induced vascular smoothmuscle cells, " Molecular Nutrition and Food Research, vol. 53, no. 12, pp. 1582-1591, 2009.
46. E. A. Goncharova, A. J. Ammit, C. Irani et al., "PI3K is required for proliferation and migration of human pulmonary vascular smooth muscle cells, " American Journal of Physiology-Lung Cellular and Molecular Physiology, vol. 283, no. 2, pp. L354-L363, 2002.
47. J. Seo, H. S. Lee, S. Ryoo, J. H. Seo, B. Min, and J. H. Lee, "Tangeretin, a citrus flavonoid, inhibits PGDF-BB-induced proliferation and migration of aortic smooth muscle cells by blocking AKT activation, " European Journal of Pharmacology, vol. 673, no. 1-3, pp. 56-64, 2011.
48. S. Chen, Y. Ding, W. Tao, W. Zhang, T. Liang, and C. Liu, "Naringenin inhibits TNF-α induced VSMC proliferation and migration via induction of HO-1, " Food and Chemical Toxicology, vol. 50, no. 9, pp. 3025-3031, 2012.
49. C. Lai, S. Li, Y. Miyauchi, M. Suzawa, C. Ho, andM. Pan, "Potent anti-cancer effects of citrus peel flavonoids in human prostate xenograft tumors, " Food and Function, vol. 4, no. 6, pp. 944-949, 2013.
50. N. M. Pandya, N. S. Dhalla, andD. D. Santani, "Angiogenesis-a new target for future therapy, " Vascular Pharmacology, vol. 44, no. 5, pp. 265-274, 2006.
51. D. Hanahan and R. A. Weinberg, "Hallmarks of cancer: the next generation, " Cell, vol. 144, no. 5, pp. 646-674, 2011.
52. T. A. Bhat and R. P. Singh, "Tumor angiogenesis: a potential target in cancer chemoprevention, " Food and Chemical Toxicology, vol. 46, no. 4, pp. 1334-1345, 2008.
53. K. Kunimasa, M. Ikekita, M. Sato et al., "Nobiletin, a citrus polymethoxyflavonoid, suppresses multiple angiogenesisrelated endothelial cell functions and angiogenesis in vivo, " Cancer Science, vol. 101, no. 11, pp. 2462-2469, 2010.
54. I. K. Lam, D. Alex, Y. H. Wang et al., "In vitro and in vivo structure and activity relationship analysis of polymethoxylated flavonoids: identifying sinensetin as a novel antiangiogenesis agent, " Molecular Nutrition and Food Research, vol. 56, no. 6, pp. 945-956, 2012.
55. K. H. Lam, D. Alex, I. K. Lam, S. K. W. Tsui, Z. F. Yang, and S. M. Y. Lee, "Nobiletin, a polymethoxylated flavonoid fromcitrus, shows anti-angiogenic activity in a zebrafish in vivo model and HUVEC in vitro model, " Journal of Cellular Biochemistry, vol. 112, no. 11, pp. 3313-3321, 2011.
56. A. Lakshmi and S. Subramanian, "Chemotherapeutic effect of tangeretin, a polymethoxylated flavone studied in 7, 12-dimethylbenz(a)anthracene induced mammary carcinoma in experimental rats, " Biochimie, vol. 99, pp. 96-109, 2014.
57. S. A. B. E. van Acker, M. J. de Groot, D. D. van Berg et al., "A quantum chemical explanation of the antioxidant activity of flavonoids, " Chemical Research in Toxicology, vol. 9, no. 8, pp. 1305-1312, 1996.
58. K. E. Heim, A. R. Tagliaferro, and D. J. Bobilya, "Flavonoid antioxidants: chemistry, metabolism and structure-activity relationships, " Journal of Nutritional Biochemistry, vol. 13, no. 10, pp. 572-584, 2002.
59. B. Mishra, K. I. Priyadarsini, M. S. Kumar, M. K. Unnikrishnan, and H. Mohan, "Effect of O-glycosilation on the antioxidant activity and free radical reactions of a plant flavonoid, chrysoeriol, " Bioorganic and Medicinal Chemistry, vol. 11, no. 13, pp. 2677-2685, 2003.
60. D. Amic andB. Lucic, "Reliability of bond dissociation enthalpy calculated by the PM6 method and experimental TEAC values in antiradical QSAR of flavonoids, " Bioorganic and Medicinal Chemistry, vol. 18, no. 1, pp. 28-35, 2010.
61. J. Zheng, M. Song, P. Dong et al., "Identification of novel bioactive metabolites of 5-demethylnobiletin in mice, " Molecular Nutrition & Food Research, vol. 57, no. 11, pp. 1999-2007, 2013.
62. S. Li, M.-H. Pan, C.-Y. Lo et al., "Chemistry and health effects of polymethoxyflavones and hydroxylated polymethoxyflavones, " Journal of Functional Foods, vol. 1, no. 1, pp. 2-12, 2009.
63. P. Dong, P. Qiu, Y. Zhu et al., "Simultaneous determination of four 5-hydroxy polymethoxyflavones by reversed-phase high performance liquid chromatography with electrochemical detection, " Journal of Chromatography A, vol. 1217, no. 5, pp. 642-647, 2010.
64. S. Li, Z. Wang, S. Sang, M. T. Huang, and C. T. Ho, "Identification of nobiletin metabolites in mouse urine, " Molecular Nutrition and Food Research, vol. 50, no. 3, pp. 291-299, 2006.